SCHEMBL20534709

SCHEMBL20534709

COc1cccc(F)c1C(C)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 1/20 0.47
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA12 O43570 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
AKR1C3 P42330 6/20 0.44
AKR1C2 P52895 6/20 0.44
PTGS2 P35354 4/20 0.43
PTGS1 P23219 3/20 0.43
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ACHE P22303 1/20 0.41
APP P05067 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 2/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31445111 1.00 KMT2A (0.47) KMT2AKDM4ECA1CA2CA12
SCHEMBL31446670 0.85 KMT2A (0.46) KMT2AKDM4ECA1CA2CA12
SCHEMBL15645990 0.84 CES2 (0.47) KMT2AKDM4EAKR1C3AKR1C2PTGS2
SCHEMBL15645912 0.84 CES2 (0.47) KMT2AKDM4EAKR1C3AKR1C2PTGS2
SCHEMBL5040787 0.82 CA12 (0.44) KMT2AKDM4ECA1CA2CA12
SCHEMBL31446707 0.80 AKR1C3 (0.52) KMT2AKDM4ECA1CA2CA12
SCHEMBL20534678 0.80 KDM4E (0.43) KMT2AKDM4ECA1CA2CA12
SCHEMBL21632310 0.80 PTGFR (0.45) KMT2AKDM4ECA1CA2CA12
SCHEMBL29888943 0.79 NFE2L2 (0.42) KMT2AKDM4ECA1CA2CA12
SCHEMBL4302733 0.79 NFE2L2 (0.42) KMT2AKDM4ECA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed
WO-2018189011-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-10-18 WO disclosed